SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-059028
Filing Date
2013-08-01
Accepted
2013-08-01 17:22:04
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-13616_110q.htm 10-Q 1149607
2 EX-31.1 a13-13616_1ex31d1.htm EX-31.1 12956
3 EX-31.2 a13-13616_1ex31d2.htm EX-31.2 13698
4 EX-32 a13-13616_1ex32.htm EX-32 11337
  Complete submission text file 0001104659-13-059028.txt   13514851

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT thrx-20130630.xml EX-101.INS 1278391
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20130630.xsd EX-101.SCH 90078
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20130630_cal.xml EX-101.CAL 54364
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20130630_lab.xml EX-101.LAB 1437184
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20130630_pre.xml EX-101.PRE 652273
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20130630_def.xml EX-101.DEF 424968
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 131003530
SIC: 2834 Pharmaceutical Preparations